Published 2007 | Version v1
Publication

Recombinant human thyroid stimulating hormone does not acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-kappaBeta ligand in patients under evaluation for differentiated thyroid carcinoma

Additional details

Created:
April 14, 2023
Modified:
November 27, 2023